MALARIA CONSORTIUM

04785712
Active London

Other human health activities

545 employees website.com
Healthcare and wellbeing Other human health activities
M

MALARIA CONSORTIUM

04785712

Other human health activities

Founded 3 Jun 2003 Active London, England 545 employees website.com
Healthcare and wellbeing Other human health activities
Accounts Submitted 9 Oct 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 25 Jun 2025 Next due 24 Jun 2026 9 days remaining
Net assets £34M £3M 2024 year on year
Total assets £229M £33M 2024 year on year
Total Liabilities £195M £30M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

The Green House Cambridge Heath Road London E2 9DA England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MALARIA CONSORTIUM (04785712), an active healthcare and wellbeing company based in London, England. Incorporated 3 Jun 2003. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type group
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2019–2024)

Cash in Bank

£142.79M

Increased by £91.39M (+178%)

Net Assets

£34.29M

Increased by £3.02M (+10%)

Total Liabilities

£195.05M

Increased by £30.02M (+18%)

Turnover

£72.21M

Decreased by £16.38M (-18%)

Employees

545

Decreased by 79 (-13%)

Debt Ratio

85%

Increased by 1 (+1%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Sarah De TournemireDirectorAmericanUnited States5612 Nov 2020Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

MALARIA CONSORTIUM Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 May 2026OfficersAppointment of Ms Jana Marie Armstrong as director on 10 May 2026
10 Apr 2026OfficersAppointment of Mr Luke Pearce as director on 1 Apr 2026
30 Mar 2026OfficersTermination of Dawa Dem as director on 16 Mar 2026
30 Mar 2026OfficersTermination of Ian Christopher Boulton as director on 16 Mar 2026
10 Feb 2026OfficersAppointment of Mr Jamal Uddin as director on 10 Feb 2026
20 May 2026 Officers

Appointment of Ms Jana Marie Armstrong as director on 10 May 2026

10 Apr 2026 Officers

Appointment of Mr Luke Pearce as director on 1 Apr 2026

30 Mar 2026 Officers

Termination of Dawa Dem as director on 16 Mar 2026

30 Mar 2026 Officers

Termination of Ian Christopher Boulton as director on 16 Mar 2026

10 Feb 2026 Officers

Appointment of Mr Jamal Uddin as director on 10 Feb 2026

Recent Activity

Latest Activity

Appointment of Ms Jana Marie Armstrong as director on 10 May 2026

3 weeks ago on 20 May 2026

Appointment of Mr Luke Pearce as director on 1 Apr 2026

2 months ago on 10 Apr 2026

Termination of Dawa Dem as director on 16 Mar 2026

2 months ago on 30 Mar 2026

Termination of Ian Christopher Boulton as director on 16 Mar 2026

2 months ago on 30 Mar 2026

Appointment of Mr Jamal Uddin as director on 10 Feb 2026

4 months ago on 10 Feb 2026